the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Tengku Zafrul: Malaysia hopes for stronger, quality FDI growth in 2024

KUALA LUMPUR: Malaysia hopes to continue attracting quality investments next year, which gives higher economic complexity and are inclusive in terms of growth for the people.

Investment, Trade and Industry Minister Tengku Datuk Seri Zafrul Abdul Aziz said as Malaysia achieved approved investments totalling RM132.6 billion in the first half of 2023 (60 per cent of the full year target), the ministry expects that it would continue to achieve more robust growth next year.

“Of course when it comes to investment, it also depends on what’s happening globally. We’ve seen trade growth moderating this year.

“We’re going to be a bit more selective (in terms of foreign direct investments), looking at the right sectors like electrical and electronics, chemical and petrochemical, and we have also just announced various tax incentives and grants for this sector,“ he said in an interview with Bloomberg News.

The initiatives include giving rebates of up to RM2,400 to buyers of electric motorbikes.

Tengku Zafrul said that the recent Budget 2024 announced by Prime Minister Datuk Seri Anwar Ibrahim is a responsible budget, noting that the prime minister also plans to implement the Fiscal Responsibility Act.

“Our budget deficit forecast is around five per cent for this year, and we expect this to go down to 4.3 per cent next year.

“Overall, it is still an expansionary budget. We expect the total budget to be around US$80 billion (RM393.8 billion),“ he added. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings